{"name":"TWi Biotechnology, Inc.","slug":"twi-biotechnology-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"immunology","drugs":[{"name":"AC-1101","genericName":"AC-1101","slug":"ac-1101","indication":"Other","status":"phase_1"},{"name":"AC-201","genericName":"AC-201","slug":"ac-201","indication":"Other","status":"phase_2"},{"name":"AC-201CR","genericName":"AC-201CR","slug":"ac-201cr","indication":"Other","status":"phase_2"},{"name":"AC-701 Topical Gel 0.3%","genericName":"AC-701 Topical Gel 0.3%","slug":"ac-701-topical-gel-0-3","indication":"Other","status":"phase_2"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AC-203","genericName":"AC-203","slug":"ac-203","indication":"Chronic pain","status":"phase_2"}]}],"pipeline":[{"name":"AC-203","genericName":"AC-203","slug":"ac-203","phase":"phase_2","mechanism":"AC-203 is a selective agonist of the kappa opioid receptor.","indications":["Chronic pain"],"catalyst":""},{"name":"AC-1101","genericName":"AC-1101","slug":"ac-1101","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AC-201","genericName":"AC-201","slug":"ac-201","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AC-201CR","genericName":"AC-201CR","slug":"ac-201cr","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AC-701 Topical Gel 0.3%","genericName":"AC-701 Topical Gel 0.3%","slug":"ac-701-topical-gel-0-3","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPMHpITkR5enRaOGh0YlREQmxkUDdKOER2LUZUNnFjbGdEbC0zMUp5ODE4QjU0SVF5M3pac0dmUjE2UGg1a3ZKM281VDQyaTRmRTQ1X3dNanFOa2JNLW1iWGJ1c21uNDRyZG8xQ1daTmMtd0lwekZCTkQzZVpkUHE4dG1RLU55MDZMNmNPV0lrLW43ZEZ1OG12ekV1VnYyVEpKcE5LYmhLdnVQbV9JOXd3cnlCVS13OXJGeWp3OGo3MA?oc=5","date":"2026-03-17","type":"pipeline","source":"Nasdaq","summary":"Epidermolysis Bullosa Market Set for Significant Upswing During the Forecast Period (2025-2034) Amid Rising Therapeutic Advancements | DelveInsight - Nasdaq","headline":"Epidermolysis Bullosa Market Set for Significant Upswing During the Forecast Period (2025-2034) Amid Rising Therapeutic ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPT0dDaXV1RFh0VF81c1ZwWVV5dmZnd3VzaTVFZkRnWlBJelY1SUdtdC1BbEdCUGtVVXRhNnFKWkx6RXIyQmxLMjVoVUZUTW9FSFJoaFktb1UzNW9qTmhLdVhaOTJlR1VrRVVmUWxENjlEN1oyR0dxcmRIRGhUc2JWd250MFpSWkhNQWxCcEx4ZDcycUpTb2hjakVlZ3RwQdIBVkFVX3lxTE5UcTE0Y1kyM3RWa0Q3SmhKUmdhWkpjNlRMeW1uRGFEc192SEozTFNCX0ZyVzJ0S2lMbXRwTWdtNS1TR1FXcFBycmJacHRDdnE4Qmhhc1BR?oc=5","date":"2026-02-06","type":"pipeline","source":"Law360","summary":"Takeda Can't Ax Most Of Heartburn Drug Pay-For-Delay Suit - Law360","headline":"Takeda Can't Ax Most Of Heartburn Drug Pay-For-Delay Suit - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxORE9kTkpmTm9RLUxVNmhnZVNpZ2VaRFhlbUVVNUpTRHdCVFNZNjRVZUY4UFI1bTgwWjF0SU0tZVo2QUZMU2p2WnNkME9La2dRcFpVS0xGTldhOFJjb25RUmdqR01QVGUzRm1OaDFRcTgxUmsxWW5FSWNzd2dxdVNDQmpyRDhrY3c4OW80a1lxRzdGSUVzRGtSeEx30gFWQVVfeXFMUHc1ZEZOQ05TUm5MUElMdmowYkxvRzRCSXk2X3JMTXRwcFMxdXJwTHgzd1I0TzM5QnNEdC1OTUNEYTZuNkRtZzZaZTF2TGFGd0J3Sjd5aWc?oc=5","date":"2025-10-30","type":"pipeline","source":"Law360","summary":"Fed. Circ. Explains Rule While Upholding Merck PTAB Loss - Law360","headline":"Fed. Circ. Explains Rule While Upholding Merck PTAB Loss - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQWnJNTDQ0QVotdzEzNnVxTWZ2ODkyaWZfeFE2eUhaNE9qMU1rRmNGNGc5Ry1DelFNRWVUcm85YVZSQUN3SE8yOEw5UTdXb0Q0b2t0dkpBdUpFRXlqRlBDcFZxV2ZSdVdRNGY2NTV5alRTSWxnOTIzZVBFYnZQQ01wcHlSNUZOMlBieExxSlNaa2FYdFlnSUNEMC0tRjJNSEJSMGE2c0hfazQyOWJ4UmFSNjJ5SElyMkZFTUIwRHNiQTB0YkhLb091Rw?oc=5","date":"2025-10-23","type":"pipeline","source":"Healio","summary":"Complete hair regrowth for some with alopecia after 3-year ritlecitinib treatment - Healio","headline":"Complete hair regrowth for some with alopecia after 3-year ritlecitinib treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOTXhWVzBNVlIyLW94dmRBQlYyM2VudTFEZFh5Mm5DUlVDdmRfb1R2MFhnd3NJWUhCN1lUWWx2SHBKN1dIbGxCeTdrTmdzd3ZqdmRSTkpsSy13U3U4U2MyTlFfN2UyMUV1aE9nSXREYmVwVVkxZGFoc1Fpa2ROS1lzYkFEd3c2MV9YblRoaFBiLTc3WlgxWmlobEoyT0VHZDdtN3hLaVhlU0pJUUFIN1NOUGpDYnFmVUpBMERyTnNB?oc=5","date":"2025-09-10","type":"pipeline","source":"Fierce Pharma","summary":"Takeda faces another 'pay-for-delay' antitrust lawsuit, this one from CVS over heartburn drug Dexilant - Fierce Pharma","headline":"Takeda faces another 'pay-for-delay' antitrust lawsuit, this one from CVS over heartburn drug Dexilant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQVzZtT2w1UFEyQ3VqOWhXQVVOOHZJc0NyR2txZEhGMEM2d3hUZXZhRng5V1hjOVlISWNscGl1MzJSVC1KS1VmRnl2Nm56OWx0MlczeFZCTHRNNjNobFFmT2tZSGFsUEQ4bElSdGxNLUNlS214bExia2FLXzNMRXFnTFZoWXI2M0NlOWtZWmtHY2JPVmlxQ1hGbDIxdlhQbTRodGFXRjdMeHFaQ1NjdGxN?oc=5","date":"2025-05-22","type":"pipeline","source":"Fierce Pharma","summary":"CDMO Bora Biologics expands operations in San Diego in wake of acquisition by Tanvex - Fierce Pharma","headline":"CDMO Bora Biologics expands operations in San Diego in wake of acquisition by Tanvex","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOakRTUWZlbjNYZVlzeWphSGY3V3U1RmkydjkwUjE5THA0d0lteVZPVEFBMlNhVnBDdGpicW9COWZHN2RGWmZaVV9XLW5LQXFUR1lsWnFsdFNKaVBsME91YmwzU0JwS2ZHWHd2RFpIb0FMZlY4MmNDcVhXazFCdFFlVTU0WkI0LWZEX3NWMGQ0MkNobUZrb0FVMkNlWlpUWUNJ?oc=5","date":"2025-05-07","type":"pipeline","source":"San Antonio Express-News","summary":"H-E-B, other retailers accuse pharmaceutical companies of having monopolies - San Antonio Express-News","headline":"H-E-B, other retailers accuse pharmaceutical companies of having monopolies - San Antonio Express","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOVC11ZjlXN1RGdXlXLUFUckZ5dEpiaW15V3lmNVFCQmh2WjNOak1fRURHYzNSa3hjWjRiR2VMZTNTb3EwYU05aVhvNHRucE9WRnFCN3JueEV4Um5YVFZsM0hNa1ROM2NKRV9ySmo2bWdfSkJBaXdCazEtM0E4T18zTjBacVFzazlpRlBhNmptZGNXa0JoazUwQ09QUF9yTVhl?oc=5","date":"2025-04-02","type":"pipeline","source":"mysanantonio.com","summary":"H-E-B is suing a Japanese pharmaceutical company. Here's why. - mysanantonio.com","headline":"H-E-B is suing a Japanese pharmaceutical company. Here's why.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPc2l0Yjk3eF9fa2M1bHlrbWNLMzF6RXpGWm4tSEphaGR5NnlBTHdUY3lrZXo0YTk1bFVvaXBvQjlCUlVWUGE5YmtGU2s0WGhZUEplUlNuV3Z4TkFGRlN2aVF2WFFFMTFfNnZjU080VHlzUC10WTdiazh1YzJ2S2R0RWZBdXVqUFFLcUpVYXIyRFBoVVJfYlVMUlZ3Y2wzYlpVNlg3eEtB?oc=5","date":"2025-03-25","type":"pipeline","source":"Bloomberg Law News","summary":"Walgreens, Kroger Sue Pharma Companies With Drug Collusion Claim - Bloomberg Law News","headline":"Walgreens, Kroger Sue Pharma Companies With Drug Collusion Claim","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQWUN1SF9tbXJvODdDQU9UR0k3T2txdkd0LUh6SE15STVsRldPMHRqUmFTN1pWQ3prOHhqd2tGOVktdWNPY3ZaTlp3NFdvRmJOWVpQbUxSUXBGYllOOFFPbHhwY2JyUEpPNDAzNW1uWndvaGdTbmR5ZE1USzFnUG54Z2wwRjBmcld0WFk4b0RXV0Rjam9vSmJFRDBPXzhKT2luQWRobzdQZFNRcURnd1JrOA?oc=5","date":"2024-01-23","type":"pipeline","source":"Pharmaceutical Commerce","summary":"Bora Pharmaceuticals Completes $210 Million Purchase of Upsher-Smith - Pharmaceutical Commerce","headline":"Bora Pharmaceuticals Completes $210 Million Purchase of Upsher-Smith","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE52T182UUcyLXdXSURGcnJVVGZybk9RNC1OQ0p0d3BDN1d1MHFWRnFSVTdSQ1NMZFp6Qmp6SFRUbG9HMEhBZWNUc3dISVVjNXgyR2FWWFJPNU9VZVpRaFhnVmxUdWFfdGpZdDVaTEg5VDNPTU5ZY0E?oc=5","date":"2023-08-18","type":"deal","source":"Taipei Times","summary":"Bora acquires six US brand product licenses, rights - Taipei Times","headline":"Bora acquires six US brand product licenses, rights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQNXNRZHVTUl8wdmhhYVdDRFQ1QlJ0SFFOTmp4aG1vcDZCdHJoT3JVTm02S0VpdzF5c0NoQ2FlWHpYcms0ckh2Zlk5MkdfZVY2TFF0WEtpZm5QSEdlVUhIbFh3dldVM01ZaUR5NnpwUVQ4NGdrX3FtQzNybzhJdElmVWFzcGU?oc=5","date":"2014-12-04","type":"pipeline","source":"JD Supra","summary":"Par Pharmaceutical, Inc. v. TWi Pharmaceuticals, Inc. (Fed. Cir. 2014) - JD Supra","headline":"Par Pharmaceutical, Inc. v. TWi Pharmaceuticals, Inc. (Fed. Cir. 2014)","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"phase_2":4,"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}